HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer

NCT06328387 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Advanced Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Hydroxychloroquine
DRUG: Sacituzumab Govitecan
DRUG: Trastuzumab Deruxtecan

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University